19.4 Maternal Health Equity, Cultural Humility & Gender-Affirming Gynecologic Care
Key Takeaways
The United States maternal mortality crisis demonstrates severe racial inequities: Black women are 3 to 4 times and Indigenous women 2 to 3 times more likely to die from pregnancy-related causes than White women, independent of income or education.
Maternal Mortality Review Committees (MMRCs) determine that >80% of pregnancy-related deaths are preventable; the leading underlying causes are mental health conditions (suicide and overdose), hemorrhage, and cardiovascular conditions.
The weathering hypothesis demonstrates how structural racism and cumulative allostatic load accelerate biological aging and vascular dysfunction, necessitating systemic interventions like AIM safety bundles and community doulas.
Cultural humility emphasizes lifelong self-critique, redressing clinical power imbalances, and viewing patients as experts in their lived experience, moving beyond the checklist approach of cultural competence.
Gender-affirming care requires organ-based preventive screening (cervical cytology for anyone with a cervix); exogenous testosterone induces amenorrhea but is NOT contraception and is teratogenic, requiring compatible progestin or copper contraception.
The United States Maternal Mortality Crisis & Racial Disparities
The United States maintains the highest maternal mortality rate among high-income nations. The Centers for Disease Control and Prevention (CDC) monitors maternal deaths using the Pregnancy-Related Mortality Ratio (PRMR), defined as the number of pregnancy-related deaths per 100,000 live births occurring during pregnancy or within one year postpartum from any cause related to or aggravated by pregnancy or its management.
Severe Racial & Ethnic Inequities
U.S. maternal mortality is characterized by persistent, stark racial disparities:
- Non-Hispanic Black Women: Experience a PRMR 3 to 4 times higher than non-Hispanic White women (approximately 40 to 55 vs. 13 to 17 deaths per 100,000 live births).
- American Indian and Alaska Native (AI/AN) Women: Experience a PRMR 2 to 3 times higher than White women.
- Independence from Socioeconomic Status: Epidemiological data show these racial disparities persist across all income levels and educational strata; a Black woman with a graduate degree faces higher maternal mortality risk than a White woman without a high school diploma, demonstrating that structural inequities rather than individual biology or socioeconomic status drive disparities.
Preventability & Leading Causes
State Maternal Mortality Review Committees (MMRCs)—multidisciplinary expert panels that investigate every maternal death—consistently report that greater than 80% of pregnancy-related deaths are preventable.
The leading underlying causes of pregnancy-related mortality include:
- Mental Health Conditions: The leading underlying cause in CDC maternal mortality review data (about 23% of pregnancy-related deaths through 2021 and about 28% in 2022), driven by suicide and overdose and concentrated in the late postpartum period (43–365 days).
- Obstetric Hemorrhage: Severe postpartum blood loss from uterine atony, placenta accreta spectrum, or genital tract trauma.
- Infection / Sepsis: Puerperal endometritis, chorioamnionitis, and septic shock.
- Cardiovascular Conditions & Cardiomyopathy: Cardiac and coronary conditions plus peripartum cardiomyopathy together rank among the top causes, especially for Black women.
- Hypertensive Disorders of Pregnancy: Preeclampsia with severe features, eclampsia, and HELLP syndrome causing intracranial hemorrhage or end-organ failure.
- Thrombotic Pulmonary Embolism: Deep venous thrombosis and pulmonary embolism fueled by pregnancy-induced hypercoagulability.
Structural Determinants, Chronic Allostatic Load & The Weathering Hypothesis
The Weathering Hypothesis
Developed by Dr. Arline Geronimus, the weathering hypothesis posits that Black women experience chronic, cumulative exposure to social adversity, systemic racism, and environmental injustice, inducing high allostatic load—chronic physiological dysregulation characterized by elevated cortisol, circulating catecholamines, and endothelial inflammation. Over decades, this chronic neuroendocrine activation accelerates biological aging and induces premature vascular dysfunction. Black women frequently enter pregnancy with underlying vascular wear and tear, significantly increasing their susceptibility to early-onset preeclampsia, chronic hypertension, and cardiovascular collapse.
Historical Medical Exploitation & Medical Mistrust
Medical mistrust in marginalized communities stems from documented systemic exploitation:
- J. Marion Sims: Developed gynecologic surgical techniques (vesicovaginal fistula repair) through non-consensual experimental surgeries on enslaved Black women (Anarcha, Betsey, Lucy) without anesthesia.
- Tuskegee Syphilis Study: Four-decade withholding of known curative penicillin therapy from Black men with syphilis by the U.S. Public Health Service.
- Coerced & Involuntary Sterilizations: Widespread federally funded involuntary sterilizations of Indigenous, Black, Puerto Rican, and disabled women throughout the 20th century (Relf v. Weinberger, 1973).
Clinicians must acknowledge this historical reality, address implicit bias, and actively build therapeutic trust.
Evidence-Based Interventions: AIM Safety Bundles & Community Doulas
- Alliance for Innovation on Maternal Health (AIM) Safety Bundles: Standardized, multidisciplinary clinical safety toolkits organized around the 4 "Rs": Readiness, Recognition & Prevention, Response, and Reporting & Systems Learning. Key bundles include:
- Severe Hypertension in Pregnancy: Mandates immediate administration of first-line intravenous antihypertensives (IV labetalol, IV hydralazine) or oral immediate-release nifedipine within 30 to 60 minutes of persistent severe-range blood pressure (systolic BP ≥160 mmHg and/or diastolic BP ≥110 mmHg).
- Obstetric Hemorrhage: Employs cumulative quantitative blood loss (QBL) measurement rather than visual estimation, stage-based hemorrhage protocols, and rapid uterotonic administration.
- Community Doula Integration: Culturally concordant doulas provide continuous labor support, patient advocacy, and postpartum accompaniment, significantly reducing cesarean delivery rates, improving maternal satisfaction, and mitigating racial disparities in clinical communication.
Cultural Humility versus Cultural Competence
| Dimension | Cultural Competence | Cultural Humility |
|---|---|---|
| Underlying Philosophy | Views culture as a static set of traits and beliefs to be mastered through checklists and educational modules. | Views culture as dynamic, intersectional, and unique to the individual; rejects the notion of cultural "mastery." |
| Primary Goal | Knowledge acquisition and behavioral competence regarding specific demographic groups. | Lifelong commitment to rigorous self-evaluation, self-critique, and awareness of implicit biases. |
| Clinical Power Dynamics | Retains traditional hierarchy where the clinician acts as the objective expert evaluating the patient. | Actively redresses clinical power imbalances, establishing partnerships where the patient is the recognized expert in their own lived experience. |
| Institutional Focus | Emphasizes individual provider interpersonal skills. | Demands institutional accountability, systemic advocacy, and structural transformation to dismantle health inequities. |
Note
Origins: Coined in 1998 by Melanie Tervalon and Jann Murray-García, cultural humility shifts medical practice from a fixed educational milestone to a continuous, lifelong process of self-critique and egalitarian partnership.
Gender-Affirming Gynecologic & Reproductive Care
Advanced practice nurses provide gynecologic care to transgender men, non-binary individuals, and gender-diverse patients with female-assigned reproductive organs.
Affirming Communication & Clinical Environment
- Inclusive Terminology: Consistently use the patient's affirmed name, legal name when necessary, and pronouns (she/her, he/him, they/them). Adopt affirming, organ-specific terms based on patient preference (e.g., "internal exam" or "front pelvic examination" instead of "vaginal exam"; "chestfeeding" or "bodyfeeding"; "gonads" or "ovaries").
- Dysphoria Reduction: Use the smallest appropriate speculum (Pedersen or pediatric), offer topical 4% lidocaine gel, allow patient-assisted speculum insertion, and offer a support chaperone.
Organ-Based Screening & Atrophy Management
- Cervical Cancer Screening: Guidelines (USPSTF/ASCCP) apply based on organ inventory, regardless of gender identity. Anyone with a cervix aged 21 to 65 requires routine cytology and hrHPV screening.
- Managing Testosterone-Induced Atrophy: Exogenous testosterone induces severe vaginal and cervical squamous atrophy, leading to dyspareunia, exam pain, and high rates of unsatisfactory cytology or false-positive ASC-US results.
- Topical Estrogen Pre-Treatment: Prescribe a 1- to 2-week course of topical vaginal estrogen (e.g., 0.01% estradiol cream or 10 mcg vaginal tablets nightly for 10–14 days) prior to repeat Pap screening. Topical estrogen restores squamous maturation and diagnostic cellularity without compromising systemic virilization or altering circulating testosterone levels.
Gender-Affirming Hormone Therapy (GAHT) & Contraceptive Counseling
- Testosterone & Amenorrhea: Exogenous testosterone induces virilization and leads to amenorrhea in 85% to 90% of patients within 3 to 6 months.
- CRITICAL FACT: Testosterone is NOT Contraception: Ovulation can occur unpredictably despite complete amenorrhea. Transgender men having intercourse with sperm-producing partners can conceive while on testosterone.
- Teratogenicity: Testosterone is a potent teratogen that causes virilization of a female fetus and reproductive tract anomalies.
- Compatible Contraception:
- Intrauterine Devices: The 52 mg levonorgestrel IUD (LNG-IUD) is an ideal first-line method; it provides >99% contraceptive efficacy, reduces residual spotting, and does not alter systemic testosterone. Copper IUDs and subdermal etonogestrel implants are also fully compatible.
- Progestin-Only Methods: DMPA and progestin-only pills (POPs) are fully compatible and do not cause feminization.
- Estrogen-Containing Methods: Generally avoided due to patient dysphoria related to potential breast tenderness or perceived feminization.
- Preconception & Fertility Preservation: Clinicians must counsel patients regarding fertility preservation options (oocyte cryopreservation, embryo banking) prior to initiating GAHT or undergoing gender-affirming gonadectomy. Testosterone must be stopped prior to conception due to teratogenic risks.
A 24-year-old transgender man who has been taking intramuscular testosterone cypionate 100 mg weekly for 2 years presents to the women's health clinic for contraception counseling. He has been completely amenorrheic for 18 months. He is sexually active with a cisgender male partner and uses condoms inconsistently. He expresses fear of becoming pregnant, noting that pregnancy would cause severe gender dysphoria. He also expresses concern that taking birth control might counteract the masculinizing effects of his testosterone therapy. What is the most accurate, evidence-based clinical guidance to provide this patient?
Amenorrhea on testosterone confirms permanent ovarian suppression; therefore, additional contraception is unnecessary while maintaining target male testosterone levels.
Testosterone is not a reliable contraceptive and is teratogenic; a 52 mg levonorgestrel-releasing IUD provides highly effective contraception without interfering with testosterone virilization.
The only compatible contraceptive method for individuals receiving testosterone therapy is permanent surgical bilateral salpingo-oophorectomy and hysterectomy.
Combined oral contraceptive pills containing ethinyl estradiol and drospirenone are first-line therapy because estrogen potentiates testosterone-induced amenorrhea.
A 29-year-old non-Hispanic Black primigravida at 34 weeks gestation presents to an outpatient obstetrics clinic reporting a persistent throbbing frontal headache and visual blurring that began the previous evening. Her clinic blood pressure is 168/112 mmHg on initial measurement and 166/110 mmHg on repeat measurement 20 minutes later. When she mentions her headache, the triage nurse notes that the patient appears anxious and attributes her symptoms to stress at work. The Women's Health Nurse Practitioner reviews the case. Recognizing the systemic racial disparities in maternal mortality and the Alliance for Innovation on Maternal Health (AIM) safety protocols, what is the required clinical action?
Reassure the patient, prescribe oral acetaminophen for tension headache, and schedule a repeat blood pressure check in 1 week.
Discharge the patient with a prescription for oral labetalol 100 mg twice daily and instruct her to monitor her blood pressure at home.
Order outpatient non-stress testing and laboratory evaluation, deferring antihypertensive medication until protein-to-creatinine ratio results return in 24 hours.
Initiate urgent intravenous antihypertensive therapy (labetalol or hydralazine) within 30 to 60 minutes and transfer immediately for inpatient maternal-fetal evaluation.
A 31-year-old transgender man who has been receiving gender-affirming testosterone therapy for 4 years presents for routine preventive healthcare. He has an intact cervix and uterus. His last cervical cancer screening was 5 years ago, and his recent Pap smear returned from the laboratory as 'Unsatisfactory for evaluation due to scant squamous cellularity and extensive cellular atrophy.' The patient reports that the pelvic speculum examination was painful due to significant dryness. What is the most appropriate next clinical step to ensure an adequate, evaluable repeat cervical cytology specimen?
Prescribe a 1- to 2-week course of topical vaginal estrogen cream prior to repeating the speculum examination and cervical cytology.
Advise the patient that cervical cancer screening is unnecessary because exogenous testosterone permanently suppresses human papillomavirus replication.
Perform an immediate random cervical punch biopsy without a repeat Pap smear to bypass the atrophic cervical epithelium.
Double the patient's weekly dose of intramuscular testosterone for 1 month to stimulate cervical glandular maturation before repeating cytology.
Sections you finish are checked off in the contents.
You've completed this section
Continue exploring other exams